Paul Balfanz

2.5k total citations
16 papers, 591 citations indexed

About

Paul Balfanz is a scholar working on Infectious Diseases, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Balfanz has authored 16 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Neurology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Balfanz's work include COVID-19 Clinical Research Studies (9 papers), Long-Term Effects of COVID-19 (9 papers) and Respiratory Support and Mechanisms (8 papers). Paul Balfanz is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), Long-Term Effects of COVID-19 (9 papers) and Respiratory Support and Mechanisms (8 papers). Paul Balfanz collaborates with scholars based in Germany, Chile and Austria. Paul Balfanz's co-authors include Michael Dreher, Nikolaus Marx, Bojan Hartmann, Dirk Müller‐Wieland, Christian Cornélissen, Ayham Daher, Tobias Müller, Annegret Müller, Ingmar Bergs and Gernot Marx and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Paul Balfanz

15 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Balfanz Germany 9 387 280 164 121 119 16 591
Ayham Daher Germany 10 365 0.9× 254 0.9× 148 0.9× 172 1.4× 123 1.0× 27 580
Bojan Hartmann Germany 8 338 0.9× 259 0.9× 144 0.9× 117 1.0× 100 0.8× 13 517
Joan Gil Spain 10 461 1.2× 318 1.1× 218 1.3× 164 1.4× 175 1.5× 16 736
Hannah C. Jarvis United States 5 523 1.4× 291 1.0× 242 1.5× 80 0.7× 128 1.1× 9 721
Emma Denneny United Kingdom 5 500 1.3× 267 1.0× 238 1.5× 121 1.0× 114 1.0× 10 667
Rajeev Jayadevan India 5 423 1.1× 210 0.8× 197 1.2× 47 0.4× 109 0.9× 8 613
Luis Vasconcello‐Castillo Chile 9 410 1.1× 178 0.6× 150 0.9× 235 1.9× 130 1.1× 14 623
Maciej Dębski Poland 13 455 1.2× 242 0.9× 226 1.4× 61 0.5× 132 1.1× 64 884
Theresa Hippchen Germany 8 340 0.9× 349 1.2× 153 0.9× 64 0.5× 97 0.8× 19 785
Xavier Alsina‐Restoy Spain 7 367 0.9× 166 0.6× 119 0.7× 215 1.8× 106 0.9× 18 523

Countries citing papers authored by Paul Balfanz

Since Specialization
Citations

This map shows the geographic impact of Paul Balfanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Balfanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Balfanz more than expected).

Fields of papers citing papers by Paul Balfanz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Balfanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Balfanz. The network helps show where Paul Balfanz may publish in the future.

Co-authorship network of co-authors of Paul Balfanz

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Balfanz. A scholar is included among the top collaborators of Paul Balfanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Balfanz. Paul Balfanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Balfanz, Paul, Dirk Müller‐Wieland, Stephan Jonas, et al.. (2024). Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study. Scientific Reports. 14(1). 30290–30290. 2 indexed citations
2.
Hannemann, Juliane, Paul Balfanz, Edgar Dahl, et al.. (2024). A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients. Scientific Reports. 14(1). 15739–15739.
3.
Hartmann, Bojan, Paul Balfanz, Niels‐Ulrik Korbinian Hartmann, et al.. (2022). Glycaemic variability is associated with all-cause mortality in COVID-19 patients with ARDS, a retrospective subcohort study. Scientific Reports. 12(1). 9862–9862. 8 indexed citations
4.
Tiburcy, Malte, Daniel Biermann, Paul Balfanz, et al.. (2022). Transmural myocardial repair with engineered heart muscle in a rat model of heterotopic heart transplantation – A proof-of-concept study. Journal of Molecular and Cellular Cardiology. 168. 3–12. 7 indexed citations
5.
Thiele, Kirsten, Paul Balfanz, Tobias Müller, et al.. (2022). Cardiopulmonary work up of patients with and without fatigue 6 months after COVID-19. Scientific Reports. 12(1). 18038–18038. 4 indexed citations
6.
Balfanz, Paul, Bojan Hartmann, Dirk Müller‐Wieland, et al.. (2021). Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19. PLoS ONE. 16(1). e0246182–e0246182. 10 indexed citations
7.
Hannemann, Juliane, Paul Balfanz, Edzard Schwedhelm, et al.. (2021). Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients. Scientific Reports. 11(1). 9895–9895. 24 indexed citations
8.
Daher, Ayham, Paul Balfanz, Bojan Hartmann, et al.. (2021). Clinical course of COVID-19 patients needing supplemental oxygen outside the intensive care unit. Scientific Reports. 11(1). 2256–2256. 24 indexed citations
9.
Ermis, Ummehan, Ana Sofia Costa, Michael Dreher, et al.. (2021). Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients. SHILAP Revista de lepidopterología. 3(1). 17–17. 48 indexed citations
10.
Daher, Ayham, Christian Cornélissen, Niels‐Ulrik Korbinian Hartmann, et al.. (2021). Six Months Follow-Up of Patients with Invasive Mechanical Ventilation Due to COVID-19 Related ARDS. International Journal of Environmental Research and Public Health. 18(11). 5861–5861. 22 indexed citations
11.
Cornélissen, Christian, Ingmar Bergs, Annegret Müller, et al.. (2021). Broncho‐alveolar lavage in patients with acute respiratory distress syndrome due to COVID‐19. Internal Medicine Journal. 51(6). 965–967. 2 indexed citations
12.
Franzen, Julia, Margherita Vieri, Miloš Nikolić, et al.. (2021). Epigenetic Clocks Are Not Accelerated in COVID-19 Patients. International Journal of Molecular Sciences. 22(17). 9306–9306. 27 indexed citations
13.
Dreher, Michael, Alexander Kersten, Johannes Bickenbach, et al.. (2020). The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Deutsches Ärzteblatt international. 117(16). 271–278. 169 indexed citations
14.
Daher, Ayham, Paul Balfanz, Christian Cornélissen, et al.. (2020). Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respiratory Medicine. 174. 106197–106197. 223 indexed citations
15.
Dreher, Michael, Johannes Bickenbach, Nikolaus Marx, et al.. (2020). Charakteristik von 50 hospitalisierten COVID-19-Patienten mit und ohne ARDS. 117(16). 20 indexed citations
16.
Tiburcy, Malte, Paul Balfanz, Buntaro Fujita, et al.. (2016). Engineered Heart Muscle from Human Embryonic Stem Cell-Derived Cardiomyocytes for Transmural Myocardial Repair. The Thoracic and Cardiovascular Surgeon. 64(S 01). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026